Global Patent Index - EP 1317281 A1

EP 1317281 A1 2003-06-11 - USE OF LIPOPEPTIDES FOR IMMUNOTHERAPY OF HIV-POSITIVE SUBJECTS

Title (en)

USE OF LIPOPEPTIDES FOR IMMUNOTHERAPY OF HIV-POSITIVE SUBJECTS

Title (de)

VERWENDUNG FON LIPOPEPTIDEN ZUR BEHANDLUNG VON HIV-PATIENTEN

Title (fr)

UTILISATION DE LIPOPEPTIDES POUR L'IMMUNOTHERAPIE DES SUJETS VIH+

Publication

EP 1317281 A1 (FR)

Application

EP 01967441 A

Priority

  • FR 0102773 W
  • FR 0011443 A
  • FR 0102846 A
  • US 23507900 P
  • US 27894201 P
  • US 10774602 A

Abstract (en)

[origin: WO0220052A1] The invention concerns the use of lipopeptides for preparing a vaccine for controlling viral rebound in HIV-positive subjects undergoing anti-retroviral therapy exhibiting a viral load of not more than 10000 copies per ml of plasma and a rate of CD4+ not less than 300 cells per mm<3>, wherein the lipopeptides consist of a peptide chain of 7 to 100 amino acids comprising at least a CTL epitope of a HIV protein, covalently bound to a lipid chain comprising 8 to 20 carbon atoms.

IPC 1-7 (main, further and additional classification)

A61K 39/21

IPC 8 full level (invention and additional information)

A61K 9/00 (2006.01); A61K 39/21 (2006.01); C07K 14/16 (2006.01); C12N 15/88 (2006.01); A61K 47/32 (2006.01)

CPC (invention and additional information)

A61K 9/0019 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); C07K 14/005 (2013.01); C12N 15/88 (2013.01); A61K 47/32 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/55544 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/57 (2013.01); C12N 2740/16322 (2013.01); C12N 2740/16334 (2013.01)

Citation (search report)

See references of WO 0220052A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

EPO simple patent family

WO 0220052 A1 20020314; AU 8782001 A 20020322; CA 2421409 A1 20020314; EP 1317281 A1 20030611; US 2006199777 A1 20060907; US 7119078 B2 20061010

INPADOC legal status


2005-04-20 [18R] REFUSED

- Effective date: 20041121

2003-11-19 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20031008

2003-06-11 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20030408

2003-06-11 [AK] DESIGNATED CONTRACTING STATES:

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

2003-06-11 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Countries: AL LT LV MK RO SI